Member Contact: Greg Collier
Position: Managing Director & CEO
Industry: Biotech & Pharmaceuticals
Invion is a life sciences company focussed on the development of treatments for major opportunities in chronic inflammatory and autoimmune diseases. The Group has a number of drug assets under development or for partnering. Invion is an ASX listed company (ASX:IVX), with operations in Melbourne, Australia and Delaware, USA. Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of Photosoft™ for the treatment of cancers. The appointment has been made by The Cho Group, a Hong Kong based group that funded and successfully commercialised a number of unique and advanced technologies.